| pubmed-article:15696570 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15696570 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:15696570 | lifeskim:mentions | umls-concept:C0334889 | lld:lifeskim |
| pubmed-article:15696570 | lifeskim:mentions | umls-concept:C0004057 | lld:lifeskim |
| pubmed-article:15696570 | lifeskim:mentions | umls-concept:C0085387 | lld:lifeskim |
| pubmed-article:15696570 | lifeskim:mentions | umls-concept:C0009488 | lld:lifeskim |
| pubmed-article:15696570 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:15696570 | lifeskim:mentions | umls-concept:C0036576 | lld:lifeskim |
| pubmed-article:15696570 | lifeskim:mentions | umls-concept:C0521115 | lld:lifeskim |
| pubmed-article:15696570 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15696570 | pubmed:dateCreated | 2005-2-10 | lld:pubmed |
| pubmed-article:15696570 | pubmed:abstractText | To evaluate the effects of cardiovascular comorbidities and aspirin coprescription on cyclooxygenase (COX)-2 inhibitor (coxib) prescribing patterns among rheumatologists. | lld:pubmed |
| pubmed-article:15696570 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15696570 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15696570 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15696570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15696570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15696570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15696570 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15696570 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15696570 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:15696570 | pubmed:author | pubmed-author:SebaldtRolf... | lld:pubmed |
| pubmed-article:15696570 | pubmed:author | pubmed-author:KremerJoelJ | lld:pubmed |
| pubmed-article:15696570 | pubmed:author | pubmed-author:ReedGeorgeG | lld:pubmed |
| pubmed-article:15696570 | pubmed:author | pubmed-author:BinghamClifto... | lld:pubmed |
| pubmed-article:15696570 | pubmed:author | pubmed-author:AbramsonSteve... | lld:pubmed |
| pubmed-article:15696570 | pubmed:author | pubmed-author:GreenbergJeff... | lld:pubmed |
| pubmed-article:15696570 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15696570 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15696570 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:15696570 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15696570 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15696570 | pubmed:pagination | 12-7 | lld:pubmed |
| pubmed-article:15696570 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:meshHeading | pubmed-meshheading:15696570... | lld:pubmed |
| pubmed-article:15696570 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15696570 | pubmed:articleTitle | Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists. | lld:pubmed |
| pubmed-article:15696570 | pubmed:affiliation | New York University-Hospital for Joint Diseases, New York, New York, USA. jeffrey.greenberg@nyumc.org | lld:pubmed |
| pubmed-article:15696570 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15696570 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15696570 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15696570 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15696570 | lld:pubmed |
